CEL-SCI Stock Price. Everything You Need To Know About The CEL-SCI Stock!
CEL-SCI Corp. is a biotechnology company headquartered in Vienna, Virginia, that is dedicated to developing innovative immunotherapy products for the treatment of cancer and infectious diseases. By activating the immune system to fight cancer and infectious diseases, CEL-SCI Corp. is leading the way in research and development for immune-based treatments.
The company’s lead investigational therapy, Multikine (Leukocyte Interleukin, Injection), is currently in a pivotal phase III clinical trial. Multikine is an investigational immunotherapy under development for the potential treatment of certain head and neck cancers.
CEL-SCI Corp. is also utilizing its Ligand Epitope Antigen Presentation System (LEAPS) technology to develop various new drug candidates, including CEL-4000 and CEL-2000, as potential rheumatoid arthritis therapeutic treatments. Additionally, the company is developing an immunotherapy using its LEAPS peptide technology with the potential to treat the coronavirus (COVID-19).
Investors interested in staying up-to-date on stocks share price today, including CEL-SCI Corp., should research the latest developments in the company’s innovative research and development efforts. It is essential to keep an eye on premarket trends to stay informed of the latest industry news. As with any investment opportunity, it is crucial to do your own research and speak with a financial advisor before making any decisions. Remember, investing involves risks, and past performance is not a guarantee of future results.
CEL-SCI Stock Price. Everything You Need To Know About The CEL-SCI Stock! performance
- Employees 0
- Company HQ Vienna
- Website http://www.cel-sci.com/
- CVM Asset Type Common Stock
- CVM Market Capitalization 78.8M
- Earnings Per Share -0.69
- Dividends Per Share None
- Dividend Date 2017-06-15
- Quarterly Earnings Growth 0
Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in the exciting world of stocks? Look no further! At Zorion, we offer a wide range of investment opportunities, including the stock of CEL-SCI. CEL-SCI is a prominent and promising company in the healthcare industry. With their cutting-edge technologies and innovative approach, CEL-SCI has positioned itself as a leader in the development of immunotherapy products for the treatment of cancer and other diseases. If you are interested in investing in CEL-SCI from Malaysia, Thailand, Indonesia, or Vietnam, we provide investment insights, recommendations, and access to educational materials to ensure you make informed investment decisions. Start your investment journey with Zorion today and unlock the potential of CEL-SCI!
